Immunomodulatory gene therapy for haematological malignancies.
about
Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMCMalignant thymoma: current status of classification and multimodality treatment.Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.
P2860
Immunomodulatory gene therapy for haematological malignancies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunomodulatory gene therapy for haematological malignancies.
@ast
Immunomodulatory gene therapy for haematological malignancies.
@en
Immunomodulatory gene therapy for haematological malignancies.
@nl
type
label
Immunomodulatory gene therapy for haematological malignancies.
@ast
Immunomodulatory gene therapy for haematological malignancies.
@en
Immunomodulatory gene therapy for haematological malignancies.
@nl
prefLabel
Immunomodulatory gene therapy for haematological malignancies.
@ast
Immunomodulatory gene therapy for haematological malignancies.
@en
Immunomodulatory gene therapy for haematological malignancies.
@nl
P2860
P1476
Immunomodulatory gene therapy for haematological malignancies.
@en
P2093
Schmidt-Wolf GD
Schmidt-Wolf IG
P2860
P356
10.1046/J.1365-2141.2002.03365.X
P407
P577
2002-04-01T00:00:00Z